Literature DB >> 26849504

New partner for Galapagos JAK drug.

.   

Abstract

Mesh：

Substances：

Year:  2016        PMID： 26849504     DOI： 10.1038/nbt0216-123

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  1 in total

1.  Pfizer's first-in-class JAK inhibitor pricey for rheumatoid arthritis market.

Authors:  Ken Garber
Journal:  Nat Biotechnol       Date:  2013-01       Impact factor: 54.908
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.